MED19 anticorps (AA 51-150) (Cy5)

N° du produit ABIN6984435

Détail du produit anti-MED19 anticorps (Cy5)

Antigène: MED19 (Mediator Complex Subunit 19 (MED19))

Épitope: AA 51-150

Reactivité: Rat

Hôte: Lapin

Clonalité: Polyclonal

Conjugué: Cet anticorp MED19 est conjugé à/à la Cy5

Application: Immunofluorescence (Cultured Cells) (IF (cc)), Immunofluorescence (Paraffin-embedded Sections) (IF (p))

Réactivité croisée: Rat

Homologie: Human,Mouse,Cow,Horse,Chicken

Purification: Purified by Protein A.

Immunogène: KLH conjugated synthetic peptide derived from human MED19/LCMR1

Isotype: IgG

Information d'application

Indications d'application: IF(IHC-P) 1:50-200
IF(IHC-F) 1:50-200
IF(ICC) 1:50-200

Restrictions: For Research Use only

Stockage

Format: Liquid

Concentration: 1 μg/μL

Buffer: Aqueous buffered solution containing 0.01M TBS ( pH 7.4) with 1 % BSA, 0.03 % Proclin300 and 50 % Glycerol.

Agent conservateur: ProClin

Précaution d'utilisation: This product contains ProClin: a POISONOUS AND HAZARDOUS SUBSTANCE, which should be handled by trained staff only.

Stock: -20 °C

Stockage commentaire: Store at -20°C. Aliquot into multiple vials to avoid repeated freeze-thaw cycles.

Date de péremption: 12 months

Détails sur MED19

Antigène: MED19 (Mediator Complex Subunit 19 (MED19))

Autre désignation: MED19 (MED19 Produits)

Sujet:

Synonyms: LCMR1, Lung cancer metastasis related protein 1, Lung cancer metastasis-related protein 1, med19, MED19_HUMAN, Mediator complex subunit 19, Mediator of RNA polymerase II transcription subunit 19, Mediator of RNA polymerase II transcription, subunit 19 homolog.

Background: MED19 is a component of the Mediator complex, which is a coactivator for DNA-binding factors that activate transcription via RNA polymerase II (Sato et al., 2003 [PubMed 12584197]).[supplied by OMIM, Oct 2008]

ID gène: 219541

UniProt: A0JLT2

Pathways: Regulation of Lipid Metabolism by PPARalpha